Used in pharmaceutical research as a key intermediate in the synthesis of serotonin receptor modulators. Its structure supports the development of compounds targeting central nervous system disorders, particularly migraine treatments. The hydroxyl and sulfonamide functional groups enhance binding affinity and selectivity toward 5-HT receptors. Also explored in the design of novel anti-inflammatory agents due to its ability to cross the blood-brain barrier and exhibit favorable pharmacokinetic properties in preclinical studies.